- Leadership Team
- Board Members
- Board of Advisors
CEO & President
CTO




CFO
Representative Director of AI Dynamics Japan




VP of Bioinformatics and Health Sciences
Shoko is joining the team as a Director of Bioinformatics. Her background is in Bioinformatics and she has lead a team to analyze sequencing and hybridization data for drug and biomarker discoveries. She’s received her Ph.D. in Japan from the University of Tokyo, then moved to the US for her postdocs. After the postdocs, she joined a startup, SecondGenome, where she worked on gut microbiome datasets to come up with microbial molecules (metabolites, proteins, and peptides) that can cure inflammatory disease, cancer, and central nervous system disorders. She is based in the San Francisco Bay Area with her husband, a 5-yr old son, and a 2-yr old dog.


CEO & President
Founding Investor/Board Member




Founding Investor/Board Member
Board Member




Board Member
Allan O’Bryant is the Executive Managing Partner of Yunzei Partners, a family office focused on early-stage investments in a variety of sectors including, healthcare, addiction treatment, energy, digital technology, and others. Allan is retired from Reinsurance Group of America (RGA) where he was Executive Vice President, Chief Corporate Officer, and a member of RGA’s Executive Council. During his storied career, Allan served in several “C” level positions in companies including AFLAC, Lehman Brothers, Yunzei Capital LLC, and KPMG. Allan is Emeritus Chair of the Board of Directors and Board of Trustees of the American School in Japan. He currently serves on several corporate and leadership boards including Novinium Inc., AI Dynamics, Harvard Law School, and Brigham Young University. He is a member of the American Institute of Certified Public Accountants. Since retirement, Allan has dedicated his philanthropic and professional efforts to helping people in recovery heal from the ravages of addiction. Using his unique skill set, Allan brings a wealth of knowledge and leadership and is positioned to help early-stage companies successfully grow.
Board Member




Advisor
Advisor




Advisor
Advisor




Advisor
Advisor




Advisor
Dr. Chad A. Highfill is an entrepreneur, investor, and scientist whose current work and expertise focus on integrating big OMICs datasets to find new therapeutic targets. Dr. Highfill started his career with Takeda Pharmaceutical Company serving as a System’s Biologist and currently serves in multiple advisor roles as a leading biotechnology expert. The most notable advisor role outside of AI Dynamics is advising Ronawk LLC on various big data analytic tools available for various OMIC datasets. He graduated from the University of Kansas with a Ph.D. in Molecular, Cellular & Developmental Biology and from Missouri State University with a MS and BS in Biology.
- Free Consultations
- Simple-to-Use AI Platform
- Build Models in Minutes instead of Months